# An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on Cognition

> **NCT07168824** · NA · ENROLLING_BY_INVITATION · sponsor: **Chi-Chang Huang** · enrollment: 40 (estimated)

## Conditions studied

- Subjective Cognitive Decline (SCD)

## Interventions

- **DIETARY_SUPPLEMENT:** Lacticaseibacillus paracasei

## Key facts

- **NCT ID:** NCT07168824
- **Lead sponsor:** Chi-Chang Huang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-10-17
- **Primary completion:** 2026-08-18
- **Final completion:** 2026-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07168824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07168824, "An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on Cognition". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07168824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*